Skip Navigation or Skip to Content

Symposium

The Structural Biology of Autism: Chromatin Remodeling and the Control of Transcription in the Context of Autism

On June 27, 2024, the NLM Family Foundation hosted a Boston Club meeting titled, “The Structural Biology of Autism: Chromatin Remodeling and the Control of Transcription in the Context of Autism.” The meeting was chaired by Prof. Clarence E. Schutt, Director & Chief Scientific Officer of the NLM Family Foundation.

The Foundation’s interest in this topic stems from the fact that after a quarter century of intensive efforts from laboratories around the world, the role of genetic mutations involved in the etiology of autism have been largely delineated. Well over a hundred genes have been identified that are known to affect two fundamental biological processes: synaptic plasticity and chromatin remodeling. Previous Boston Clubs have taken up the question of how impaired synapses affect neurodevelopment and the normal functioning of global neuronal circuits in sensory, motor, and speech activities, contributing to the symptoms of autism. CHD8, a member of a class of proteins known as chromatin remodelers, has emerged as one of the most important non-synaptic proteins contributing to autism.

In the cell nucleus, DNA comprising genes are packaged in nucleosomes in which 146 base pairs wrap around a core of histone proteins. Nucleosomes themselves are arranged into densely-packed higher order structures which need to be opened up to allow access for RNA polymerase to transcribe genes into the messenger RNA that is read by ribosomes to produce proteins. During memory formation, for example, when neurons need a fresh supply of protein to re-shape synapses, CHD8 is activated to pry open nucleosomes to initiate the remodeling of chromatin.  Impairment due to mutation of this process can lead to serious problems during neurodevelopment and sensory, motor, and language processing.

Structural Biology is the science of discovering the molecular structures of proteins and protein-DNA complexes, as well as a host of other entities that make up cells and organelles. Structures at atomic resolution can be used to design drugs and address the ramifications of mutations in essential proteins.

This Boston Club explored recent developments in the field of chromatin remodeling and transcriptional regulation with a specific emphasis on high resolution protein structures known to be important for understanding autism.

Chromatin remodeling at the molecular level: How motor-like proteins reposition nucleosomes by ratcheting DNA around the histone core

Gregory D. Bowman, Ph.D.
Professor, Department of Biophysics
Johns Hopkins University

Marta Benedetti, Dr. Biol. Sciences
Senior Scientist, SFARI
Director, Autism BrainNet
Simons Foundation
Jackie Chua
Malik Dahlan, Queen Mary University of London School of Law
Marcello Distasio, MD, Ph.D.
Assistant Professor, Yale Departments of Pathology and of Ophthalmology and Visual Science; Neuropathology and Autopsy Pathology Services
Co-director, Yale Legacy Tissue Donation Program
Yale University School of Medicine
Matt Durno
Executive Director of Development, Principal and Major Gifts & Grants
Harvard Medical School
Gary Duberstein, JD
President
Parkside Pharmaceuticals, Inc.
 Structural Basis of the Chromatin Remodeler CHD8 in Autism
Lucas Farnung, Ph.D.
Assistant Professor of Cell Biology
Department of Cell Biology, Blavatnik Institute
Harvard Medical School
Brian Go
Brian Hafler, MD, Ph.D.
Assistant Professor of Ophthalmology and Visual Science and of Pathology
Yale University School of Medicine
Jacob Hooker, Ph.D.
Scientific Director
Lurie Center for Autism
Lurie Family Professor of Radiology in the Field of Autism Research
Phyllis and Jerome Lyle Rappaport MGH Research Scholar
DEAF1- Transcriptional Regulator of Neurodevelopment

Phil Jensik, Ph.D.
Associate Professor of Physiology
Southern Illinois University School of Medicine

Epigenetic underpinnings of emerging neurodevelopmental disorders and the gene- gene/gene-environment interactions linked to ASD

Erica Korb, Ph.D.
Assistant Professor, Department of Genetics
Epigenetics Institute
University of Pennsylvania Perelman School of Medicine

Robert Landreth
Robert & Donna Landreth Foundation
Julia Sommer, Ph.D.
Senior Scientist, SFARI
Scientific Lead, IPSC Repository
Simons Foundation
 

Janet Wallace, Ph.D.
Senior Scientist I
Team DOPE Program Manager
Harvard University

Sarah Yamani
The Role of Bromodomains in the Control of Transcription

Ming-Ming Zhou, Ph.D.
Dr. Harold and Golden Lamport Professor in Physiology & Biophysics
Chairman of the Department of Pharmacological Sciences
Icahn School of Medicine at Mount Sinai

2024

The Nancy Lurie Marks Family Foundation, Wellesley, MA